Search | IOVS | ARVO Journals

Showing 1 – 20 of 83

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Articles March 2021

Reliability of Retinal Pathology Quantification in Age-Related Macular Degeneration: Implications for Clinical Trials and Machine Learning Applications

PDF

Philipp L. Müller; Bart Liefers; Tim Treis; Filipa Gomes Rodrigues; Abraham Olvera-Barrios; Bobby Paul; Narendra Dhingra; Andrew Lotery; Clare Bailey; Paul Taylor; Clarisa I. Sánchez; Adnan Tufail
TAGS: age-related macular degeneration, machine learning, pathology, reliability, drusen, diagnostic imaging
Trans. Vis. Sci. Tech.. 2021; 10(3):4. doi: https://doi.org/10.1167/tvst.10.3.4

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2020

C-Reactive protein levels and the Outer retina in a large cohort study: UK Biobank

Sharon Yu Lin Chua; Paul J Foster; Andrew J Lotery; Tariq Aslam; Charles A Reisman; Tunde Peto; Catherine A Egan; Baljean Dhillon; Praveen J Patel

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2313. doi:

ARVO Annual Meeting Abstract June 2020

Real world outcomes for aflibercept in diabetic macula edema

Haralabos Eleftheriadis; Irene Mary Stratton; James S Talks; Peter Henry Scanlon; Shahram Kashani; Andrew J Lotery; Clare Bailey; Raj Mukherjee; Usha Chakravarthy

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3290. doi:

ARVO Annual Meeting Abstract June 2020

Phenome-wide association analysis on risk variants for age-related macular degeneration reveals shared genetic influences with a wide range of disorders: the Million Veteran Program

Robert Igo; Tyler G Kinzy; Christopher W. Halladay; Dana C. Crawford; Paul B Greenberg; Jack M. Sullivan; Steven J. Fliesler; Wen-Chih Wu; Helene Choquet; Karina Patasova; Eric Jorgenson; Pirro G Hysi; Andrew J Lotery; Jessica Cooke Bailey; Neal S. Peachey; Sudha K Iyengar

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3518. doi:

ARVO Annual Meeting Abstract June 2020

Implementing digital applications for self-monitoring of visual function in the MONARCH study: technological and practical challenges.

Ruth E Hogg; Robin Wickens; Charlene Treanor; Abby O'Connell; Lucy Culliford; Chris Rogers; Eleanor Gidman; Tunde Peto; Paul C Knox; Ben Burton; Andrew J Lotery; Sobha Sivaprasad; Michael Donnelly; Barney Reeves

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3079. doi:

Genetics June 2020

Rare Genetic Variants in Complement Factor I Lead to Low FI Plasma Levels Resulting in Increased Risk of Age-Related Macular Degeneration

PDF

Thomas M. Hallam; Kevin J. Marchbank; Claire L. Harris; Clive Osmond; Victoria G. Shuttleworth; Helen Griffiths; Angela J. Cree; David Kavanagh; Andrew J. Lotery
TAGS: age-related macular degeneration, cohort studies, complement factor i, cultural formulation interview, fibrinogen, genetics, plasma, regression analysis, genetic analysis
Invest. Ophthalmol. Vis. Sci.. 2020; 61(6):18. doi: https://doi.org/10.1167/iovs.61.6.18

Includes: Supplemental Content

Clinical and Epidemiologic Research May 2020

Ambient Air Pollution Associations with Retinal Morphology in the UK Biobank

PDF

Sharon Y. L. Chua; Anthony P. Khawaja; Andrew D. Dick; James Morgan; Baljean Dhillon; Andrew J. Lotery; Nicholas G. Strouthidis; Charles Reisman; Tunde Peto; Peng T. Khaw; Paul J. Foster; Praveen J. Patel; on behalf of The UK Biobank Eye and Vision Consortium
TAGS: air pollution, biobanks, language morphology, morphology
Invest. Ophthalmol. Vis. Sci.. 2020; 61(5):32. doi: https://doi.org/10.1167/iovs.61.5.32

ARVO Annual Meeting Abstract July 2019

Long-term clinical management of neovascular AMD and visual acuity outcome in IVAN trial participants

Barney Reeves; Rebecca Evans; Simon P Harding; Andrew Lotery; Usha Chakravarthy

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1214. doi:

ARVO Annual Meeting Abstract July 2019

Preliminary results in 18 patients undergoing retinal gene therapy for X-linked retinitis pigmentosa with codon-optimized AAV8-RPGR

Robert E MacLaren; Janet L Davis; Ninel Gregori; Jasmina Cehajic-Kapetanovic; Byron L Lam; Andrew Lotery; Cristina Martinez-Fernandez dela Camara; Anika Nanda; Anna Paola Salvetti; Paulo Stanga; Kanmin Xue

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1329. doi:

ARVO Annual Meeting Abstract July 2019

Oral human-equivalent L-DOPA/Carbidopa dosages administered during the postnatal critical period of neuroplasticity rescues retinal morphology and visual function in a mouse model of human albinism

Aida Sanchez-Bretano; Jennifer Ann Scott; Tutte Newall; Savannah Lynn; Helen Griffiths; Ahmed Salman; Andrew Lotery; J. Arjuna Ratnayaka; James Edward Self; Helena Lee

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1393. doi:

ARVO Annual Meeting Abstract July 2019

Aflibercept in the real world – an EPR based clinical audit of patients with diabetic macular edema from 21 UK hospitals

Sajjad Mahmood; Irene Mary Stratton; Raj Mukherjee; James S Talks; Clare Bailey; Andrew Lotery; Shahram Kashani; Faruque Ghanchi; Salim Natha; Peter Henry Scanlon

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2626. doi:

ARVO Annual Meeting Abstract July 2019

Aflibercept in the real world – are the visual outcomes worse in patients with diabetic macular edema who have had a cataract operation?

Irene Mary Stratton; Peter Henry Scanlon; James S Talks; Usha Chakravarthy; Raj Mukherjee; Faruque Ghanchi; Sajjad Mahmood; Andrew Lotery

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2637. doi:

ARVO Annual Meeting Abstract July 2019

The Influence of Corticosteroids on Choroidal Endothelial Cells in Central Serous Chorioretinopathy

Rebecca Kaye; David R. G. Christensen; Andrew Lotery

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4326. doi:

ARVO Annual Meeting Abstract July 2019

Designing a clinical trial to evaluate the safety and efficacy of oral soraprazan in Stargardt Disease

Carel C B Hoyng; Andrew Lotery; Katarina Stingl; Camiel Boon; Maurizio Parodi; Patty Dhooge; Tobias Peters; Wolfgang Klein; Mario G Fsadni; Hans Müller; Oliver Jungmann

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5704. doi:

ARVO Annual Meeting Abstract July 2019

Acceptability of OCT Angiography: A multicentre OCT Angiography NEtwork (OCTANE) study.

Faruque Ghanchi; Corinne Fulcher; Sobha Sivaprasad; Konstantinos Balaskas; Richard Peter Gale; Gabriella De Salvo; James S Talks; Andrew Lotery; Ian A Pearce

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3477. doi:

ARVO Annual Meeting Abstract July 2019

Modelling Sorsby’s Fundus Dystrophy using patient-derived iPSC-RPE

Jennifer Dewing; David R. G. Christensen; Heidi Hongisto; Jennifer Scott; Ben Jenkins; Angela Jane Cree; Heli Skottman; J. Arjuna Ratnayaka; Andrew Lotery

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):424. doi:

ARVO Annual Meeting Abstract July 2019

Characterization of the retinal phenotype of the C57BL/6-c2J mouse model of human oculocutaneous albinism: implications for treatment development

Jennifer Ann Scott; Aida Sanchez-Bretano; Helen Griffiths; Jon Ward; Chiamaka Dibigbou; Flavie Soubigou; James Edward Self; Andrew Lotery; J. Arjuna Ratnayaka; Helena Lee

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):529. doi:

ARVO Annual Meeting Abstract July 2019

Proof of concept for oral Levodopa treatment in rescuing retinal morphology and visual function in a murine model of human albinism

Helena Lee; Jennifer Scott; Helen Griffiths; James Edward Self; Andrew Lotery

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):530. doi:

ARVO Annual Meeting Abstract July 2018

Retinal Gene Therapy for Choroideremia in a Multicenter Dose Escalation Phase I/II Clinical Trial

Robert E MacLaren; Kanmin Xue; Alun R Barnard; Maria In?s Patrício; Thomas L Edwards; Susan Downes; Andrew Lotery; Graeme Black; Andrew Webster; Jasleen K Jolly; Miguel C Seabra

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1195. doi:

ARVO Annual Meeting Abstract July 2018

Efficacy of Aflibercept for the treatment of diabetic macular oedema in patients refractory to Ranibizumab.

Holly Clarke; Anastasios Sepetis; Christina Rennie; Andrew Lotery; Debendra Sahu; Dario Inzerillo; Bhaskar Gupta

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3606. doi:

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Reliability of Retinal Pathology Quantification in Age-Related Macular Degeneration: Implications for Clinical Trials and Machine Learning Applications

C-Reactive protein levels and the Outer retina in a large cohort study: UK Biobank

Real world outcomes for aflibercept in diabetic macula edema

Phenome-wide association analysis on risk variants for age-related macular degeneration reveals shared genetic influences with a wide range of disorders: the Million Veteran Program

Implementing digital applications for self-monitoring of visual function in the MONARCH study: technological and practical challenges.

Rare Genetic Variants in Complement Factor I Lead to Low FI Plasma Levels Resulting in Increased Risk of Age-Related Macular Degeneration

Ambient Air Pollution Associations with Retinal Morphology in the UK Biobank

Long-term clinical management of neovascular AMD and visual acuity outcome in IVAN trial participants

Preliminary results in 18 patients undergoing retinal gene therapy for X-linked retinitis pigmentosa with codon-optimized AAV8-RPGR

Oral human-equivalent L-DOPA/Carbidopa dosages administered during the postnatal critical period of neuroplasticity rescues retinal morphology and visual function in a mouse model of human albinism

Aflibercept in the real world – an EPR based clinical audit of patients with diabetic macular edema from 21 UK hospitals

Aflibercept in the real world – are the visual outcomes worse in patients with diabetic macular edema who have had a cataract operation?

The Influence of Corticosteroids on Choroidal Endothelial Cells in Central Serous Chorioretinopathy

Designing a clinical trial to evaluate the safety and efficacy of oral soraprazan in Stargardt Disease

Acceptability of OCT Angiography: A multicentre OCT Angiography NEtwork (OCTANE) study.

Modelling Sorsby’s Fundus Dystrophy using patient-derived iPSC-RPE

Characterization of the retinal phenotype of the C57BL/6-c2J mouse model of human oculocutaneous albinism: implications for treatment development

Proof of concept for oral Levodopa treatment in rescuing retinal morphology and visual function in a murine model of human albinism

Retinal Gene Therapy for Choroideremia in a Multicenter Dose Escalation Phase I/II Clinical Trial

Efficacy of Aflibercept for the treatment of diabetic macular oedema in patients refractory to Ranibizumab.

To View More...

You must be signed into an individual account to use this feature.